| scholarly article | Q13442814 |
| P50 | author | Chris Edens | Q57048039 |
| Mark Prausnitz | Q83738800 | ||
| Paul A. Rota | Q88475153 | ||
| P2093 | author name string | James L Goodson | |
| Marcus L Collins | |||
| P2860 | cites work | Targeted, Needle-Free Vaccinations in Skin using Multilayered, Densely-Packed Dissolving Microprojection Arrays | Q61609414 |
| A world without measles | Q64127992 | ||
| Expanded programme on immunization. Stability of vaccines | Q68895856 | ||
| Administration of measles vaccine by dermojet | Q70065184 | ||
| Comparative trial of live attenuated measles vaccine in Hong Kong by intramuscular and intradermal injection | Q71100192 | ||
| Intradermal administration of measles vaccines | Q72782022 | ||
| Biomechanical evaluation of the motor function of the thumb | Q79254404 | ||
| Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques | Q81524434 | ||
| Monitoring progress towards measles elimination | Q82796131 | ||
| Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination | Q82976466 | ||
| Global Vaccine Action Plan. Decade of vaccine collaboration | Q86894524 | ||
| Microneedle patches: usability and acceptability for self-vaccination against influenza | Q30575700 | ||
| Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity | Q33664783 | ||
| Unsafe injections in the developing world and transmission of bloodborne pathogens: a review | Q33791766 | ||
| Dissolving polymer microneedle patches for influenza vaccination | Q34049972 | ||
| Measles antibody: reevaluation of protective titers | Q34251667 | ||
| Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population | Q34333245 | ||
| Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques | Q34582862 | ||
| Biological feasibility of measles eradication | Q35038217 | ||
| Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses | Q35672048 | ||
| Microneedles for drug and vaccine delivery | Q36164749 | ||
| Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch | Q36175711 | ||
| Dissolving microneedles for transdermal drug delivery | Q36540738 | ||
| Measles vaccination using a microneedle patch | Q36997297 | ||
| Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. | Q37239980 | ||
| Measles studies in the macaque model | Q37388559 | ||
| Vaccine wastage in Bangladesh | Q37589014 | ||
| Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications | Q38105616 | ||
| Microneedle patches for vaccine delivery | Q38178693 | ||
| Global eradication of measles: an epidemiologic and economic evaluation | Q38869991 | ||
| Alternative routes of measles immunization: a review | Q38958647 | ||
| Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs | Q42926559 | ||
| Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery | Q43548910 | ||
| Global control and regional elimination of measles, 2000-2012. | Q44522255 | ||
| Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination | Q44561676 | ||
| Experimental measles. II. Infection and immunity in the rhesus macaque | Q44841030 | ||
| Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains | Q45747385 | ||
| Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection | Q45777774 | ||
| Comparative efficacy of a canine distemper-measles and a standard measles vaccine for immunization of rhesus macaques (Macaca mulatta). | Q46104602 | ||
| Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery | Q46468179 | ||
| Persistence of vaccine-induced antibody to measles 26-33 years after vaccination | Q47708271 | ||
| Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza | Q48007477 | ||
| Research priorities for global measles and rubella control and eradication. | Q51372691 | ||
| Measles vaccination in Zaïre--when and how? | Q54135588 | ||
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | measles | Q79793 |
| vaccine | Q134808 | ||
| measles vaccine | Q6804161 | ||
| P304 | page(s) | 4712-4718 | |
| P577 | publication date | 2015-03-11 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | A microneedle patch containing measles vaccine is immunogenic in non-human primates | |
| P478 | volume | 33 |
| Q52559076 | A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques. |
| Q47102442 | A review of measles control in Kenya, with focus on recent innovations |
| Q64126869 | Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016 |
| Q38748979 | Alternative administration routes and delivery technologies for polio vaccines |
| Q38630763 | Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery. |
| Q52628920 | Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact? |
| Q38860500 | Considerations in the use of microneedles: pain, convenience, anxiety and safety |
| Q86028630 | Cutaneous vaccination - Protective immunization is just a skin-deep step away |
| Q39440948 | Dissolving Microneedle Patches for Dermal Vaccination |
| Q38863128 | Exploring new packaging and delivery options for the immunization supply chain. |
| Q92437518 | Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment |
| Q47200188 | In-vitro and in-vivo assessment of polymer microneedles for controlled transdermal drug delivery |
| Q55970012 | Measles |
| Q60015402 | Measles |
| Q24050082 | Measles 50 Years After Use of Measles Vaccine |
| Q94562443 | Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa |
| Q38560170 | Measles vaccine: Past, present, and future |
| Q41006286 | Microfabrication for Drug Delivery |
| Q38770048 | Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses |
| Q38646712 | Microneedle patches for vaccination in developing countries. |
| Q38681048 | Microneedles for vaccine delivery: challenges and future perspectives. |
| Q64892049 | Microneedle‐based intradermal delivery of stabilized dengue virus. |
| Q37197084 | Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems |
| Q47141816 | Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection |
| Q46432510 | Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future |
| Q52602778 | Noninvasive vaccination against infectious diseases. |
| Q30238913 | Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies |
| Q50169459 | Polymeric microneedles for transdermal protein delivery |
| Q93024663 | Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery |
| Q94562492 | Recent setbacks in measles elimination: the importance of investing in innovations for immunizations |
| Q64266084 | Spray-Formed Layered Polymer Microneedles for Controlled Biphasic Drug Delivery |
| Q90398951 | Technology update: dissolvable microneedle patches for vaccine delivery |
| Q36037373 | The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunization |
| Q62487991 | The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains |
| Q90389809 | The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization |
| Q38799509 | The success of microneedle-mediated vaccine delivery into skin. |
| Q50700027 | Time for an immunisation paradigm shift. |
| Q36105826 | Transdermal Delivery of Drugs with Microneedles-Potential and Challenges |
| Q40115092 | Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis |
| Q36373260 | Variability in Humoral Immunity to Measles Vaccine: New Developments |
Search more.